University of Alberta Rural North General Surgery Study Material
Wednesday, November 18, 2009
Methotrexate
Antifolate antimetabolite used in both benign and malignant diseases. Notably IBD, Breast ca, SCC and sarcomas.
- inhibits dihydrofolate reductase preventing nucleotide synthesis
Myelosuppression is the most common SE and is dose-limiting
No comments:
Post a Comment